Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Medicure Inc.

Market Cap 10.85M 7.77M 6.71M 6.19M 5.79M 739M 11.02M 73.06M 28.48M 360M 29.18M 28.55M 1.25B P/E Ratio 2024
-8.8x
P/E Ratio 2025 -1.68x
Enterprise Value 7.91M 5.67M 4.89M 4.51M 4.22M 538M 8.03M 53.24M 20.76M 262M 21.26M 20.81M 908M EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
73.4%
Yield 2024 *
-
Yield 2025 -
1 day-3.70%
1 week-3.70%
Current month-6.31%
1 month-11.86%
3 months+9.47%
6 months-6.31%
Current year-8.77%
1 week 1.04
Extreme 1.04
1.04
1 month 1.04
Extreme 1.04
1.2
Current year 0.85
Extreme 0.85
1.35
1 year 0.85
Extreme 0.85
1.43
3 years 0.63
Extreme 0.63
1.8
5 years 0.63
Extreme 0.63
1.8
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 1997-09-14
Director of Finance/CFO - 2022-05-31
Chief Tech/Sci/R&D Officer - 2019-06-30
Director TitleAgeSince
Chairman 79 1997-09-14
Director/Board Member 92 2000-02-27
Director/Board Member 56 2013-01-21
Date Insider Type Main position Quantity % Market Cap.
25-03-27Option

Chief Technology Officer

7,500 0.0719%
25-03-27Option

Director

7,200 0.0690%
25-03-27Option

Chief Financial Officer

1,350 0.0129%
Change 5-day change 1-year change 3-year change Capi.($)
-3.70%-3.70%-1.89%-7.14% 7.75M
+1.03%+2.30%+54.92%+111.78% 55.58B
+2.72%+3.06%+53.28%+47.85% 43.47B
+1.06%+2.35%-14.08%-17.89% 22.64B
+0.46%+2.53%-0.28%+395.41% 20.96B
+3.81%-4.13%+16.62%-30.70% 15.79B
+0.15%+0.50%+9.10%-40.04% 15.3B
-0.49%+0.72%+27.05%+178.05% 13.45B
+5.27%+6.41%+21.05% - 11.74B
+1.61%+1.17%+90.79%+212.97% 10.96B
Average +1.22%-0.80%+25.66%+94.48% 20.99B
Weighted average by Cap. +1.67%+1.60%+33.60%+99.96%

Financials

2024 2025
Net sales 21.91M 15.69M 13.55M 12.49M 11.69M 1.49B 22.25M 147M 57.49M 726M 58.89M 57.63M 2.51B 28.86M 20.67M 17.85M 16.45M 15.4M 1.96B 29.3M 194M 75.73M 956M 77.56M 75.91M 3.31B
Net income -1.04M -744K -643K -592K -554K -70.73M -1.06M -6.99M -2.73M -34.43M -2.79M -2.73M -119M -7.1M -5.08M -4.39M -4.05M -3.79M -483M -7.21M -47.77M -18.63M -235M -19.08M -18.67M -814M
Net Debt -6.32M -4.52M -3.91M -3.6M -3.37M -430M -6.41M -42.52M -16.58M -209M -16.98M -16.62M -725M -2.94M -2.11M -1.82M -1.68M -1.57M -200M -2.99M -19.82M -7.73M -97.55M -7.91M -7.75M -338M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
26-06-08 1.040 $ -3.70% 1,665
26-06-04 1.080 $ -2.70% 5,600
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!